Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. Academic Article uri icon

Overview

publication date

  • August 3, 2016

Identity

Scopus Document Identifier

  • 84990175413

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2016.07.097

PubMed ID

  • 27496397

Additional Document Info

volume

  • 143

issue

  • 1